Liver Transplantation for Early Intrahepatic Cholangiocarcinoma (LT for iCCA)
Liver Transplantation for the Treatment of Early Stages of Intrahepatic Cholangiocarcinoma in Cirrhotics
Sponsor: University Health Network, Toronto
Terminated
Low accrual
Other terminated trials from University Health Network, Toronto
- ACL Injury · Apr 2026
- Endometrial Carcinoma · Phase PHASE2/PHASE3 · May 2025
- Central Venous Catheter Thrombosis · Phase PHASE3 · Oct 2024
- Hepatocellular Carcinoma · Phase PHASE2 · Feb 2024
- Lung Cancer · Phase NA · Nov 2023
See all terminations from University Health Network, Toronto
Other Intrahepatic Cholangiocarcinoma trials with similar outcome
This PHASE2 trial investigates Intrahepatic Cholangiocarcinoma and is currently terminated or withdrawn. University Health Network, Toronto leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Jan 2025 — Present [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Aug 2023 — Jul 2024 [monthly]
Recruiting PHASE2
-
May 2022 — Aug 2023 [monthly]
Recruiting PHASE2
▶ Show 6 earlier versions
-
Jan 2021 — May 2022 [monthly]
Recruiting PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Jan 2020 — Sep 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jan 2020 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Nov 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Nov 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .